$BPTH
BIO-PATH HOLDINGS, INC.

2016 Q3 Form 10-Q Financial Statement

#000114420416132840 Filed on November 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q3 2015 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $680.0K $520.0K
YoY Change 30.77% -26.76%
% of Gross Profit
Research & Development $2.313M $992.0K
YoY Change 133.17% 133.68%
% of Gross Profit
Depreciation & Amortization $50.00K $50.00K
YoY Change 0.0% 25.0%
% of Gross Profit
Operating Expenses $2.994M $1.512M
YoY Change 98.02% 31.01%
Operating Profit -$2.994M -$1.512M
YoY Change 98.02% 31.01%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $1.424M $4.000K
YoY Change 35500.0% -29.81%
Pretax Income -$1.570M -$1.510M
YoY Change 3.97% 31.3%
Income Tax
% Of Pretax Income
Net Earnings -$1.570M -$1.508M
YoY Change 4.11% 31.31%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$3.271M -$3.356M
COMMON SHARES
Basic Shares Outstanding 95.65M shares 89.76M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.30M $9.850M
YoY Change 14.72% -32.72%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $1.110M $200.8K
YoY Change 452.86% -30.77%
Inventory
Prepaid Expenses $196.0K
Receivables
Other Receivables
Total Short-Term Assets $12.41M $10.46M
YoY Change 18.64% -29.94%
LONG-TERM ASSETS
Property, Plant & Equipment $66.00K $82.27K
YoY Change -19.78%
Goodwill
YoY Change
Intangibles $969.0K $1.130M
YoY Change -14.28% -12.44%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.030M $1.213M
YoY Change -15.07% 1733.98%
TOTAL ASSETS
Total Short-Term Assets $12.41M $10.46M
Total Long-Term Assets $1.030M $1.213M
Total Assets $13.44M $11.67M
YoY Change 15.14% -28.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $120.0K $127.1K
YoY Change -5.6% 43.62%
Accrued Expenses $750.0K $354.1K
YoY Change 111.8% 86.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $870.0K $481.2K
YoY Change 80.79% 71.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.200M
YoY Change
Total Long-Term Liabilities $3.200M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $870.0K $481.2K
Total Long-Term Liabilities $3.200M $0.00
Total Liabilities $4.070M $481.2K
YoY Change 745.75% 71.87%
SHAREHOLDERS EQUITY
Retained Earnings -$23.93M
YoY Change
Common Stock $89.76K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.380M $11.19M
YoY Change
Total Liabilities & Shareholders Equity $13.44M $11.67M
YoY Change 15.14% -28.32%

Cashflow Statement

Concept 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$1.570M -$1.508M
YoY Change 4.11% 31.31%
Depreciation, Depletion And Amortization $50.00K $50.00K
YoY Change 0.0% 25.0%
Cash From Operating Activities -$1.910M -$1.220M
YoY Change 56.56% 19.61%
INVESTING ACTIVITIES
Capital Expenditures -$30.00K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$30.00K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.010M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -1.910M -1.220M
Cash From Investing Activities -30.00K 0.000
Cash From Financing Activities 9.010M 0.000
Net Change In Cash 7.070M -1.220M
YoY Change -679.51% 11.93%
FREE CASH FLOW
Cash From Operating Activities -$1.910M -$1.220M
Capital Expenditures -$30.00K $0.00
Free Cash Flow -$1.880M -$1.220M
YoY Change 54.1% 28.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
196000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
992000 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
520000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
1512000 USD
CY2015Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-1508000 USD
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
560000 USD
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 USD
CY2016Q3 us-gaap Revenues
Revenues
0 USD
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
681000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2994000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-1570000 USD
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
95645 shares
us-gaap Adjustment For Amortization
AdjustmentForAmortization
121000 USD
us-gaap Depreciation
Depreciation
31000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-364000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
733000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-71000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6537000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
2445000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
121000 USD
us-gaap Depreciation
Depreciation
31000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
250000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
100000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-81000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4004000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-4004000 USD
CY2014Q4 us-gaap Cash
Cash
13859000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
283000 USD
CY2016Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
100000 USD
CY2015Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
100000 USD
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
95645224 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5752000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1300000 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7052000 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5420000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.05
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.55
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.33
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2400000 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
100000 USD
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
969000 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1090000 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66000 USD
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2100000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2000000 USD
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-25000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9007000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9007000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0137 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0165 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.09 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2016Q3 bpth Drug Supplier Commitments Development
DrugSupplierCommitmentsDevelopment
200000 USD
CY2016Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3199000 USD
CY2015Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0 USD
CY2016Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1420000 USD
CY2015Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1420000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2016Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5882352 shares
CY2016Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000000 USD
CY2016Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
9300000 USD
bpth Development Project Service Evaluation Exchange Cost
DevelopmentProjectServiceEvaluationExchangeCost
50000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
4619000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-1420000 USD
CY2016Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3199000 USD
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0114 pure
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
1.04 pure
us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P5Y3M18D
CY2016Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
4600000 USD
CY2016Q3 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
3200000 USD
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
1400000 USD
CY2016Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
300000 USD
CY2015Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0 USD

Files In Submission

Name View Source Status
0001144204-16-132840-index-headers.html Edgar Link pending
0001144204-16-132840-index.html Edgar Link pending
0001144204-16-132840.txt Edgar Link pending
0001144204-16-132840-xbrl.zip Edgar Link pending
bpth-20160930.xml Edgar Link completed
bpth-20160930.xsd Edgar Link pending
bpth-20160930_cal.xml Edgar Link unprocessable
bpth-20160930_def.xml Edgar Link unprocessable
bpth-20160930_lab.xml Edgar Link unprocessable
bpth-20160930_pre.xml Edgar Link unprocessable
chart18.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v451932_10q.htm Edgar Link pending
v451932_ex31.htm Edgar Link pending
v451932_ex32.htm Edgar Link pending